Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06979375) titled 'A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy' on May 15.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Novo Nordisk A/S
Condition:
Heart Failure
Intervention:
Drug: CDR132L
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: July 1, 2025
Target Sa...